Literature DB >> 10481905

Narcolepsy: a key role for hypocretins (orexins)

J M Siegel1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10481905      PMCID： PMC8841059          DOI： 10.1016/s0092-8674(00)81969-8

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


× No keyword cloud information.
  19 in total

1.  Feeding response to central orexins.

Authors:  D C Sweet; A S Levine; C J Billington; C M Kotz
Journal:  Brain Res       Date:  1999-03-13       Impact factor: 3.252

2.  The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene.

Authors:  L Lin; J Faraco; R Li; H Kadotani; W Rogers; X Lin; X Qiu; P J de Jong; S Nishino; E Mignot
Journal:  Cell       Date:  1999-08-06       Impact factor: 41.582

3.  Distribution of orexin receptor mRNA in the rat brain.

Authors:  P Trivedi; H Yu; D J MacNeil; L H Van der Ploeg; X M Guan
Journal:  FEBS Lett       Date:  1998-10-30       Impact factor: 4.124

Review 4.  Genetic and familial aspects of narcolepsy.

Authors:  E Mignot
Journal:  Neurology       Date:  1998-02       Impact factor: 9.910

5.  The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity.

Authors:  L de Lecea; T S Kilduff; C Peyron; X Gao; P E Foye; P E Danielson; C Fukuhara; E L Battenberg; V T Gautvik; F S Bartlett; W N Frankel; A N van den Pol; F E Bloom; K M Gautvik; J G Sutcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

6.  Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior.

Authors:  T Sakurai; A Amemiya; M Ishii; I Matsuzaki; R M Chemelli; H Tanaka; S C Williams; J A Richardson; G P Kozlowski; S Wilson; J R Arch; R E Buckingham; A C Haynes; S A Carr; R S Annan; D E McNulty; W S Liu; J A Terrett; N A Elshourbagy; D J Bergsma; M Yanagisawa
Journal:  Cell       Date:  1998-02-20       Impact factor: 41.582

7.  Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation.

Authors:  R M Chemelli; J T Willie; C M Sinton; J K Elmquist; T Scammell; C Lee; J A Richardson; S C Williams; Y Xiong; Y Kisanuki; T E Fitch; M Nakazato; R E Hammer; C B Saper; M Yanagisawa
Journal:  Cell       Date:  1999-08-20       Impact factor: 41.582

8.  Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin.

Authors:  A N van den Pol; X B Gao; K Obrietan; T S Kilduff; A B Belousov
Journal:  J Neurosci       Date:  1998-10-01       Impact factor: 6.167

9.  Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y.

Authors:  J C Erickson; K E Clegg; R D Palmiter
Journal:  Nature       Date:  1996-05-30       Impact factor: 49.962

10.  Neuronal activity in narcolepsy: identification of cataplexy-related cells in the medial medulla.

Authors:  J M Siegel; R Nienhuis; H M Fahringer; R Paul; P Shiromani; W C Dement; E Mignot; C Chiu
Journal:  Science       Date:  1991-05-31       Impact factor: 47.728
View more
  50 in total

1.  Selective enhancement of synaptic inhibition by hypocretin (orexin) in rat vagal motor neurons: implications for autonomic regulation.

Authors:  Scott F Davis; Kevin W Williams; Weiye Xu; Nicholas R Glatzer; Bret N Smith
Journal:  J Neurosci       Date:  2003-05-01       Impact factor: 6.167

Review 2.  Energy expenditure: role of orexin.

Authors:  Jennifer A Teske; Vijayakumar Mavanji
Journal:  Vitam Horm       Date:  2012       Impact factor: 3.421

Review 3.  The Neurobiology of Anesthetic Emergence.

Authors:  Vijay Tarnal; Phillip E Vlisides; George A Mashour
Journal:  J Neurosurg Anesthesiol       Date:  2016-07       Impact factor: 3.956

Review 4.  [The neurophysiology of cataplexy].

Authors:  G Mayer
Journal:  Nervenarzt       Date:  2005-12       Impact factor: 1.214

Review 5.  Cataplexy associated with narcolepsy: epidemiology, pathophysiology and management.

Authors:  Michael J Thorpy
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

6.  Expression of prokineticins and their receptors in the adult mouse brain.

Authors:  Michelle Y Cheng; Frances M Leslie; Qun-Yong Zhou
Journal:  J Comp Neurol       Date:  2006-10-20       Impact factor: 3.215

7.  Rapid changes in glutamate levels in the posterior hypothalamus across sleep-wake states in freely behaving rats.

Authors:  Joshi John; Lalini Ramanathan; Jerome M Siegel
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-09-24       Impact factor: 3.619

Review 8.  Intranasal administration of orexin peptides: Mechanisms and therapeutic potential for age-related cognitive dysfunction.

Authors:  Coleman B Calva; Jim R Fadel
Journal:  Brain Res       Date:  2018-08-24       Impact factor: 3.252

Review 9.  Benefits and risks of pharmacotherapy for narcolepsy.

Authors:  Merrill M Mitler; Roza Hayduk
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

10.  Selective action of orexin (hypocretin) on nonspecific thalamocortical projection neurons.

Authors:  Laurence Bayer; Emmanuel Eggermann; Benoît Saint-Mleux; Danièle Machard; Barbara E Jones; Michel Mühlethaler; Mauro Serafin
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.